Lataa...
New frontiers in the treatment of Type 1 diabetes
Type 1 diabetes is an autoimmune disease caused by the immune-mediated destruction of pancreatic β-cells that results in lifelong absolute insulin deficiency. For nearly a century, insulin replacement has been the only therapy for most people living with this disease. Recent advances in technology a...
Tallennettuna:
| Julkaisussa: | Cell Metab |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6986815/ https://ncbi.nlm.nih.gov/pubmed/31839487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2019.11.017 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|